From: Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients
Variables (group 1 vs group2) | MSN | Claudin7 | ||||
---|---|---|---|---|---|---|
 | P value | Odds Ratio | CI | P value | Odds Ratio | CI |
Age* | 0.206 | Â | Â | 0.196 | Â | Â |
Stage^ | 0.29 | 1.401 | 0.741-2.664 | 1 | 1.033 | 0.546-1.962 |
Tumor size^ | 0.013 | 2.305 | 1.168-4.724 | 0.759 | 0.876 | 0.456-1.673 |
Lymho-vascular involvement^ | 0.098 | 0.616 | 0.344-1.096 | 0.413 | 1.255 | 0.707-2.236 |
Lymph node status | 1 | 1.018 | 0.47-2.2 | 0.365 | 0.685 | 0.314-1.48 |
Depth of myometrial invasion^ | 0.305 | 1.323 | 0.776-2.262 | 0.442 | 0.797 | 0.467-1.358 |
Grade_FIGO^ | < 0.001 | 2.561 | 1.501-4.41 | < 0.001 | 0.389 | 0.226-0.665 |
Grade_nuclear^ | < 0.001 | 2.557 | 1.504-4.385 | 0.001 | 0.419 | 0.245-0.711 |
Subtype# | < 0.001 | 0.311 | 0.154-0.609 | 0.002 | 2.628 | 1.353-5.253 |
Recurrence# | 0.867 | 0.935 | 0.456-1.925 | 0.309 | 1.479 | 0.722-3.061 |
Recurrence^ | 0.867 | 0.928 | 0.454-1.903 | 0.401 | 1.383 | 0.678-2.852 |
Status# | 0.567 | 0.847 | 0.462-1.554 | 0.112 | 1.623 | 0.885-3.007 |
Status^ | 1 | 1.015 | 0.468-2.226 | 0.278 | 1.53 | 0.705-3.386 |